Lindbrook Capital, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$19,084
-19.0%
380
+1.9%
0.00%
-33.3%
Q2 2023$23,574
+66.9%
373
+18.8%
0.00%
+50.0%
Q1 2023$14,127
+158.0%
314
+151.2%
0.00%
+100.0%
Q4 2022$5,476
-71.2%
125
-57.6%
0.00%
-66.7%
Q3 2022$19,000
+26.7%
2950.0%0.00%
+50.0%
Q2 2022$15,000
-25.0%
295
-4.2%
0.00%
-33.3%
Q1 2022$20,000
-80.6%
308
-67.8%
0.00%
-81.2%
Q4 2021$103,000957
+95600.0%
0.02%
Q3 2021$0
-100.0%
1
-95.8%
0.00%
Q2 2021$2,0000.0%24
+4.3%
0.00%
Q1 2021$2,0000.0%23
+53.3%
0.00%
Q4 2020$2,000150.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders